Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.

[1]  K. Ulm,et al.  Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,. , 2016, British journal of anaesthesia.

[2]  R. Pino,et al.  Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. , 2015, British journal of anaesthesia.

[3]  D. Reuter,et al.  Recovery from prolonged deep rocuronium-induced neuromuscular blockade , 2015, Der Anaesthesist.

[4]  M. Hollmann,et al.  Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. , 2015, British journal of anaesthesia.

[5]  H. Fennema,et al.  Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients , 2014, Anesthesiology.

[6]  Chie Nagata,et al.  Three suspected cases of sugammadex-induced anaphylactic shock , 2014, BMC Anesthesiology.

[7]  J. Takeda,et al.  [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients]. , 2014, Masui. The Japanese journal of anesthesiology.

[8]  Yuguang Huang,et al.  Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects , 2014, BMC Anesthesiology.

[9]  C. Kluft,et al.  Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects. , 2014, International journal of clinical pharmacology and therapeutics.

[10]  N. Nanjappa,et al.  Sugammadex Hypersensitivity—A Case of Anaphylaxis , 2014, Anaesthesia and intensive care.

[11]  P. Platt,et al.  Intraoperative Anaphylaxis to Sugammadex and a Protocol for Intradermal Skin Testing , 2014, Anaesthesia and intensive care.

[12]  Y. Shim,et al.  Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients , 2013, Korean journal of anesthesiology.

[13]  J. Kotani,et al.  Hypersensitivity reaction probably induced by sugammadex. , 2012, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists.

[14]  M. Hübler,et al.  A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery * , 2012, Anaesthesia.

[15]  A. Matsunaga,et al.  Three cases of suspected sugammadex-induced hypersensitivity reactions. , 2012, British journal of anaesthesia.

[16]  Y. Motoyama,et al.  [Case of anaphylactic reaction caused by sugammadex]. , 2012, Masui. The Japanese journal of anesthesiology.

[17]  M. Allard,et al.  Use of sugammadex in patients with a history of pulmonary disease. , 2012, Journal of clinical anesthesia.

[18]  T. Sloan,et al.  Residual neuromuscular blockade at extubation: A randomized comparison of sugammadex and neostigmine reversal of rocuronium-induced blockade in patients undergoing abdominal surgery , 2011 .

[19]  J. R. Ortiz-Gómez,et al.  Allergy to low dose sugammadex , 2011, Anaesthesia.

[20]  N. Brister,et al.  Efficacy, Safety, and Pharmacokinetics of Sugammadex for the Reversal of Rocuronium-induced Neuromuscular Blockade in Elderly Patients , 2011, Anesthesiology.

[21]  H. Sparr,et al.  Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. , 2010, British journal of anaesthesia.

[22]  K. Ulm,et al.  Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block , 2010, Anesthesiology.

[23]  J. Scholz,et al.  Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial , 2010, European journal of anaesthesiology.

[24]  H. Lemmens,et al.  Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine. , 2010, BMC anesthesiology.

[25]  C. Holleman,et al.  ORIGINAL ARTICLE: Can sugammadex save a patient in a simulated ‘cannot intubate, cannot ventilate’ situation? , 2010, Anaesthesia.

[26]  B. Debaene,et al.  A Randomized, Dose-Response Study of Sugammadex Given for the Reversal of Deep Rocuronium- or Vecuronium-Induced Neuromuscular Blockade Under Sevoflurane Anesthesia , 2010, Anesthesia and analgesia.

[27]  K. Khuenl-Brady,et al.  Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial , 2010, Anesthesia and analgesia.

[28]  T. Heier,et al.  Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery , 2009, European journal of anaesthesiology.

[29]  K. Candiotti,et al.  Reversal of Profound Neuromuscular Block by Sugammadex Administered Three Minutes after Rocuronium: A Comparison with Spontaneous Recovery from Succinylcholine , 2009, Anesthesiology.

[30]  P. White,et al.  The Effect of Residual Neuromuscular Blockade on the Speed of Reversal with Sugammadex , 2009, Anesthesia and analgesia.

[31]  B. Plaud,et al.  Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients , 2009, Anesthesiology.

[32]  R. Soto,et al.  Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with Neostigmine , 2008, Anesthesiology.

[33]  J. Driessen,et al.  Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. , 2008, British journal of anaesthesia.

[34]  M. Eikermann,et al.  Reversal of Profound, High-dose Rocuronium–induced Neuromuscular Blockade by Sugammadex at Two Different Time Points: An International, Multicenter, Randomized, Dose-finding, Safety Assessor–blinded, Phase II Trial , 2008, Anesthesiology.

[35]  C. Meistelman,et al.  Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. , 2008, British journal of anaesthesia.

[36]  A. Bom,et al.  Selective relaxant binding agents for reversal of neuromuscular blockade. , 2007, Current opinion in pharmacology.

[37]  M. Struys,et al.  Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane , 2007, Anesthesia and analgesia.

[38]  R. Soto,et al.  A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular Block , 2007, Anesthesia and analgesia.

[39]  P. Hans,et al.  Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent , 2007, Anesthesiology.

[40]  J. Stensballe,et al.  Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex: A Dose-finding and Safety Study , 2006, Anesthesiology.

[41]  S. Ramael,et al.  First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.

[42]  A. Bom,et al.  Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. , 2002, Journal of medicinal chemistry.

[43]  Mark Bradley,et al.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. , 2002, Angewandte Chemie.

[44]  T. Heier,et al.  Efficacy of Tactile-guided Reversal from Cisatracurium-induced Neuromuscular Block , 1998, Anesthesiology.

[45]  P. Lindholm,et al.  Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[46]  C. Motamed,et al.  Severe reaction following sugammadex injection: hypersensitivity? , 2012, Journal of investigational allergology & clinical immunology.

[47]  M. Giovannelli,et al.  Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. , 2006, British journal of anaesthesia.